Search Results - "Lynch, Joseph P"

Mucormycosis by Reid, Gail, Lynch, 3rd, Joseph P, Fishbein, Michael C, Clark, Nina M

“…Mucormycosis is an infection caused by a group of filamentous molds within the order Mucorales. Infections may result from ingestion of contaminated food,…”
Get more information

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli by Zhanel, George G., Golden, Alyssa R., Zelenitsky, Sheryl, Wiebe, Karyn, Lawrence, Courtney K., Adam, Heather J., Idowu, Temilolu, Domalaon, Ronald, Schweizer, Frank, Zhanel, Michael A., Lagacé-Wiens, Philippe R. S., Walkty, Andrew J., Noreddin, Ayman, Lynch III, Joseph P., Karlowsky, James A.

“…Cefiderocol is an injectable siderophore cephalosporin discovered and being developed by Shionogi & Co., Ltd., Japan. As with other β-lactam antibiotics, the…”
Get full text

Antimicrobial Resistance in Hospital-Acquired Gram-Negative Bacterial Infections by Mehrad, Borna, MBBS, Clark, Nina M., MD, Zhanel, George G., PhD, Lynch, Joseph P., MD, FCCP

“…Aerobic gram-negative bacilli, including the family of Enterobacteriaceae and non-lactose fermenting bacteria such as Pseudomonas and Acinetobacter species,…”
Get full text

Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment by Lynch, 3rd, Joseph P, Kajon, Adriana E

“…Adenoviruses (AdVs) are DNA viruses that typically cause mild infections involving the upper or lower respiratory tract, gastrointestinal tract, or…”
Get more information

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines by Lynch, Joseph P, Zhanel, George G

“…PURPOSE OF REVIEWStreptococcus pneumoniae (pneumococcus) remains an important cause of pneumonia, meningitis, bacteremias, and acute otitis media worldwide…”
Get full text

Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review by Belperio, John A, Shaikh, Faisal, Abtin, Fereidoun G, Fishbein, Michael C, Weigt, S. Samuel, Saggar, Rajan, Lynch, Joseph P

“…IMPORTANCE: Sarcoidosis is an inflammatory granulomatous disease of unknown cause that affects an estimated 2 to 160 people per 100 000 worldwide and can…”
Get full text

Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis by Tung, Roderick, MD, FHRS, Bauer, Brenton, MD, Schelbert, Heinrich, MD, Lynch, Joseph P., MD, Auerbach, Martin, MD, Gupta, Pawan, MD, Schiepers, Christiaan, MD, Chan, Samantha, Ferris, Julie, BA, Barrio, Martin, MS, Ajijola, Olujimi, MD, PhD, Bradfield, Jason, MD, FHRS, Shivkumar, Kalyanam, MD, PhD, FHRS

“…Background The incidence of myocardial inflammation in patients with unexplained cardiomyopathy referred for ventricular arrhythmias (VAs) is unknown…”
Get full text

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations by Zhanel, George G., Lawrence, Courtney K., Adam, Heather, Schweizer, Frank, Zelenitsky, Sheryl, Zhanel, Michael, Lagacé-Wiens, Philippe R. S., Walkty, Andrew, Denisuik, Andrew, Golden, Alyssa, Gin, Alfred S., Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

“…Relebactam (formerly known as MK-7655) is a non-β-lactam, bicyclic diazabicyclooctane, β-lactamase inhibitor that is structurally related to avibactam,…”
Get full text

Mechanisms of pulmonary fibrosis by Thannickal, Victor J, Toews, Galen B, White, Eric S, Lynch, 3rd, Joseph P, Martinez, Fernando J

“…Tissue injury evokes highly conserved, tightly regulated inflammatory responses and less well-understood host repair responses. Both inflammation and repair…”
Get full text

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis by McCormack, Francis X, Inoue, Yoshikazu, Moss, Joel, Singer, Lianne G, Strange, Charlie, Nakata, Koh, Barker, Alan F, Chapman, Jeffrey T, Brantly, Mark L, Stocks, James M, Brown, Kevin K, Lynch, Joseph P, Goldberg, Hilary J, Young, Lisa R, Kinder, Brent W, Downey, Gregory P, Sullivan, Eugene J, Colby, Thomas V, McKay, Roy T, Cohen, Marsha M, Korbee, Leslie, Taveira-DaSilva, Angelo M, Lee, Hye-Seung, Krischer, Jeffrey P, Trapnell, Bruce C

“…This trial showed that in patients with lymphangioleiomyomatosis (LAM), a progressive, cystic lung disease in women, sirolimus therapy was associated with…”
Get full text

Emergence of antimicrobial resistance among Acinetobacter species: a global threat by Clark, Nina M, Zhanel, George G, Lynch, 3rd, Joseph P

“…Bacteria within the genus Acinetobacter [principally Acinetobacter baumannii-calcoaceticus complex (ABC)] are Gram-negative coccobacilli that may cause serious…”
Get full text

Adenovirus by Lynch, 3rd, Joseph P, Fishbein, Michael, Echavarria, Marcela

“…Adenoviruses (AdV) are DNA viruses that typically cause mild infections involving the upper or lower respiratory tract, gastrointestinal (GI) tract, or…”
Get more information

Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy by Lynch, 3rd, Joseph P, Zhanel, George G

“…(PA), a non-lactose-fermenting gram-negative bacillus, is a common cause of nosocomial infections in critically ill or debilitated patients, particularly…”
Get more information

Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment by Lynch, 3rd, Joseph P, Zhanel, George G

“…MRSA is associated with causing a variety of infections including skin and skin structure infections, catheter and device-related (e.g. central venous…”
Get more information

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination by Zhanel, George G., Lawson, Christopher D., Adam, Heather, Schweizer, Frank, Zelenitsky, Sheryl, Lagacé-Wiens, Philippe R. S., Denisuik, Andrew, Rubinstein, Ethan, Gin, Alfred S., Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

“…Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and…”
Get full text

Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli by Zhanel, George G., Chung, Phillip, Adam, Heather, Zelenitsky, Sheryl, Denisuik, Andrew, Schweizer, Frank, Lagacé-Wiens, Philippe R. S., Rubinstein, Ethan, Gin, Alfred S., Walkty, Andrew, Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

“…Ceftolozane is a novel cephalosporin currently being developed with the β-lactamase inhibitor tazobactam for the treatment of complicated urinary tract…”
Get full text

Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13 by Zhanel, George G, Lynch, Joseph P, Adam, Heather J

“…Abstract Background Streptococcus pneumoniae continues to be an important bacterial pathogen associated with invasive (e.g. bacteraemia, meningitis) and…”
Get full text

Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent by Zhanel, George G., Esquivel, Jenine, Zelenitsky, Sheryl, Lawrence, Courtney K., Adam, Heather J., Golden, Alyssa, Hink, Rachel, Berry, Liam, Schweizer, Frank, Zhanel, Michael A., Bay, Denice, Lagacé-Wiens, Philippe R. S., Walkty, Andrew J., Lynch, Joseph P., Karlowsky, James A.

“…Omadacycline is a novel aminomethylcycline antibiotic developed as a once-daily, intravenous and oral treatment for acute bacterial skin and skin structure…”
Get full text

The allograft injury marker CXCL9 determines prognosis of anti‐HLA antibodies after lung transplantation by Shino, Michael Y., Zhang, Qiuheng, Li, Ning, Derhovanessian, Ariss, Ramsey, Allison, Saggar, Rajan, Britton, Ian N., Amubieya, Olawale O., Lari, Shahrzad M., Hickey, Michelle, Reed, Elaine F., Noble, Paul W., Stripp, Barry R., Fishbein, Gregory A., Lynch, Joseph P., Ardehali, Abbas, Sayah, David M., Weigt, S. Sam, Belperio, John A.

“…Despite the common detection of non‐donor specific anti‐HLA antibodies (non‐DSAs) after lung transplantation, their clinical significance remains unclear. In…”
Get full text

Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia by Lama, Vibha N, Flaherty, Kevin R, Toews, Galen B, Colby, Thomas V, Travis, William D, Long, Qi, Murray, Susan, Kazerooni, Ella A, Gross, Barry H, Lynch, Joseph P., III, Martinez, Fernando J

“…Exercise-induced hypoxia is an index of the severity of interstitial lung disease. We hypothesized that desaturation during a 6-minute walk test would predict…”
Get full text